Tue 04/25/2023 06:25 AM
Relevant Items:Preliminary OM
Covenant Analysis
Historical Financials on Fundamentals by Reorg
Transaction Overview
Germany-based specialty pharmaceutical company Cheplapharm is marketing €750 million senior secured notes due 2030. The new issue will be split between a fixed rate tranche and floating rate tranche.
The proceeds from the offering, together with the proceeds from a drawdown under the group’s existing RCF, cash on hand and a deferred purchase payment, will be used to finance...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.